TRAF2 and breast carcinoma: Notwithstanding, evidence from meta-analysis and bioinformatics validations indicates that TRAF2 and TRAF4 are highly expressed in primary and metastatic tumours55,56, and their elevated level of expression is associated with metastasis and survival rate in breast cancer patients54,57.